covid
Buscar en
Anales de Pediatría Continuada
Toda la web
Inicio Anales de Pediatría Continuada Hepatitis autoinmune
Información de la revista
Vol. 1. Núm. 2.
Páginas 80-85 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 1. Núm. 2.
Páginas 80-85 (enero 2003)
Acceso a texto completo
Hepatitis autoinmune
Visitas
15458
Pilar Codoñer
Profesora titular de Pediatría. Hospital Universitario Dr. Peset. Universitat de València. Valencia. España.
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
F. Alvarez.
Autoimmune hepatitis.
Liver Disease in Children, 2nd ed, pp. 429-441
[2.]
A.J. Czaja, M.P. Manns.
The validity and importance of subtypes of autoimmune hepatitis: a point of view.
Am J Gastroenterol, 90 (1995), pp. 1206-1211
[3.]
A.J. Czaja, F. Casani, M. Cataleta, P. Valentini, F.F. Bianchi.
Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis.
Hepatology, 24 (1996), pp. 1068-1073
[4.]
M. Gueguen, O. Boniface, O. Bernard, F. Clerc, T. Cartwright, F. Alvarez.
Identification of the main epitope on human cytochrome P450IID6 recognized by anti-liver kidney microsome antibody.
J Autoimmun, 4 (1991), pp. 607-615
[5.]
P. Codoñer Franch, K. Paradis, M. Gueguen, O. Bernard, A. Amar-Costesec, F. Alvarez.
A new antigen recognized by anti-liver-kideny-microsome antibody (LKMA).
Clin Exp Immunol, 75 (1989), pp. 354-358
[6.]
E. Martini, N. Abuaf, F. Cavalli, V. Durand, C. Johanet, J.C. Homberg.
Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2.
Hepatology, 8 (1988), pp. 1662-1666
[7.]
S. Kanzler, C. Weidemann, G. Gerken, H.F. Löhr, P.R. Galle, K.H. Meyer zum Büschenfelde, A.W. Lohse.
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis J Hepatol, 31 (1999), pp. 635-640
[8.]
E. Stechemesser, R. Klein, P.A. Berg.
Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis.
Hepatology, 18 (1993), pp. 1-9
[9.]
E. Ballot, J.C. Homberg, C. Johanet.
Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis.
J Hepatol, 33 (2000), pp. 208-215
[10.]
J.C. Homberg, N. Abuaf, O. Bernard, S. Islam, F. Alvarez, S.H. Khalil, et al.
Chronic active hepatitis associated with antiliver/ kidney microsome antibody type 1: a second type of ”autoimmune“ hepatitis.
Hepatology, 7 (1987), pp. 1333-1339
[11.]
O. Bernard, M. Hadchouel, J. Scotto, M. Odievre, D. Alagille.
Severe giant cell hepatitis with autoimmune haemolytic anemia in early childhood.
J Pediatr, 99 (1981), pp. 704-711
[12.]
J. Medina, L. García-buey, R. Moreno-Otero.
Immunopathogenetic and therapeutic aspects of autoimmune hepatitis.
Aliment Pharmacol Ther, 17 (2003), pp. 1-16
[13.]
K.M. Boberg.
Prevalence and epidemiology of autoimmune hepatitis.
Clin Liver Dis, 6 (2002), pp. 347-359
[14.]
A.J. Czaja, P.T. Donaldson.
Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis.
Immunol Rev, 174 (2000), pp. 250-259
[15.]
M. Pando, J. Larriba, G.C. Fernández, H. Fainbom, M. Ciocca, M. Ramonet, et al.
Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition.
Hepatology, 30 (1999), pp. 374-380
[16.]
I. Djilali-Saiah, P. Ouellette, S. Caillat-Zucman, D. Debray, J.I. Kohn, F. Alvarez.
CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis.
Hum Immunol, 62 (2001), pp. 1356-1362
[17.]
P.L. Bittencourt, A.C. Goldberg, E.L.R. Cancado, G. Porta, F.J. Carrilho, A.Q. Farias, et al.
Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2.
Am J Gastroenterol, 94 (1999), pp. 1906-1913
[18.]
L. Wen, Y. Ma, D.P. Bogdanos, F.S. Wong, A. Demaine, G. Mieli- Vergani, et al.
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity.
Curr Mol Med, 1 (2001), pp. 379-389
[19.]
L. Muratori, M. Parola, A. Ripalti, G. Robino, P. Muratori, G. Bellomo, et al.
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
Gut, 46 (2000), pp. 553-561
[20.]
L. Fainbom, M.C. Canero Velasco, C.Y. Marcos, M. Ciocca, A. Roy, G. Theiler, et al.
Protected, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis.
Hepatology, 33 (2001), pp. 512-517
[21.]
P. Codoñer Franch, V. Ordiñana, E. Gasco, J. Villalba, F. Alvarez.
Anti-rat liver microsomal and cytosolic antibodies in Hepatitis c virus infection.
Autoimmunity, 17 (1994), pp. 89-94
[22.]
E.L. Krawitt.
Autoimmune hepatitis.
N Engl J Med, 334 (1996), pp. 897-903
[23.]
I.G. McFarlane.
The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis.
Gut, 42 (1998), pp. 599-602
[24.]
G. Maggiore, F. Veber, O. Bernqard, M. Hadchouel, J.C. Homberg, F. Alvarez, et al.
Autoimmune hepatitis associated with antiactin antibodies in children and adolescents.
J Pediatr Gastroenterol Nutr, 17 (1993), pp. 376-381
[25.]
P. Codoñer Franch, O. Bernard, G. Maggiore, D. Alagille, F. Alvarez.
Clinical and immunological heterogeneity of anti-liver- kideny microsome antibody-positive autoimmune hepatitis in children.
J Pediatr Gastroenterol Nutr, 9 (1989), pp. 436-440
[26.]
P. Lapierre, O. Hajoui, J.C. Homberg, F. Alvarez.
Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis.
Gastroenterology, 116 (1999), pp. 643-649
[27.]
P. Codoñer Franch, V. Ordiñana García, M.D. Tío Guillamón, Y. Fernández Delgado, R. Cerdá.
Hepatitis autoinmune anticitosol hepático (Anti-LC1).
An Esp Pediatr, 42 (1995), pp. 146-148
[28.]
J. Herkel, B. Heidrich, N. Nieraad, I. Wies, M. Rether, A.W. Lohse.
Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
Hepatology, 35 (2002), pp. 403-408
[29.]
A.J. Czaja, K.D. Pfeifer, R.H. Decker, A.S. Vallari.
Frequency and significance of antibodies to asialogycoprotein receptor in type 1 autoimmune hepatitis.
Dig Dis Sci, 41 (1996), pp. 1733-1740
[30.]
D. Zauli, S. Ghetti, A. Grassi, C. Descovich, F. Cassani, G. Ballardini, et al.
Antineutrophil cytoplasmic antibodies in type 1 and type 2 autoimmune hepatitis.
Hepatology, 25 (1997), pp. 1105-1107
[31.]
W.F. Balistreri, M.H. Chang, M. Ciocca, K. Schwarz, G. Porta, A. Vegnente, et al.
Acute and Chronic Hepatitis:Working Group of the First Congress of Pediatric Gastroenterology, Hepatology, and Nutrition.
J Pediatr Gastroenterol Nutr, 35 (2002), pp. S62-S73
[32.]
F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, E.L. Cancado, et al.
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.
J Hepatol, 31 (1999), pp. 929-938
[33.]
F. Alvarez, K. Schwarz.
Immune diseases of the liver and biliary tract.
J Pediatr Gastroenterol Nutr, 35 (2002), pp. S39-S43
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos